Vitamin D Treatment to Patients Suffering From Chronic Pain and Vitamin D Hypovitaminosis
|ClinicalTrials.gov Identifier: NCT01023490|
Recruitment Status : Completed
First Posted : December 2, 2009
Last Update Posted : October 16, 2012
|Condition or disease||Intervention/treatment||Phase|
|Back Pain Hypovitaminosis D||Drug: Vitamin D Drug: Placebo||Not Applicable|
Vitamin D is a complex nutrient that functions as a hormone to benefit numerous body tissues.
Vitamin D is naturally produced by skin exposed to ultraviolet B. Despite the fact that Israel is a sunny country, a majority of all patients, and particularly those with pain, have inadequate intake of vitamin D.
Vitamin D therapy is easy for patients to self administer, well tolerated, and very economical.
In this study, we'll check whether vitamin D will lead to a decrease in pain intensity in patients suffering from chronic low back pain.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||12 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||A Randomised, Double-blind, Placebo-controlled Study to Check Whether Vitamin D Will Lead to a Decrease in Pain Intensity in Patients Suffering From Chronic Pain and Hypovitaminosis D|
|Study Start Date :||January 2010|
|Actual Primary Completion Date :||October 2012|
|Actual Study Completion Date :||October 2012|
U.S. FDA Resources
|Placebo Comparator: Placebo||
Active Comparator: Vitamin D
34,500 IU vitamin D per week
Drug: Vitamin D
34,5000 IU vitamin D per week
- The objective of this study is to check whether vitamin D will lead to a decrease in pain intensity compare to placebo, in patients suffering from chronic pain. [ Time Frame: one year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01023490
|Tel Aviv Sourasky Medical Center, Pain Medicine Unit|
|Tel Aviv, Israel|